Medi Caps Ltd-$
Medi Caps Ltd-$ (MEDICAPQ) last reported results for the quarter ended Jun 2026, with sales of ₹2.79 crore and net profit of ₹-2.23 crore. The stock last traded at ₹25.5, a market capitalisation of ₹30.4 crore. Over the past 52 weeks the stock has ranged between ₹20.3 and ₹44.7. Figures are as of 9 Oct 2026 and are not real time.
Medi Caps Ltd-$ share price and key metrics
- Current price
- ₹25.5
- Market cap
- ₹30.4 cr
- Book value
- ₹89.5
- ROE
- -9.21%
- ROCE
- -9.19%
- Dividend yield
- 0.00%
- 52w high / low
- 44.7/20.3
Metrics as of 9 Oct 2026. Not real time.
Track Medi Caps Ltd-$
Cruxal reads every Medi Caps Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Medi Caps Ltd-$ growth and returns
- 10 Years
- -12%
- 5 Years
- -26%
- 3 Years
- -37%
- TTM
- -43%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 49%
- 10 Years
- 1%
- 5 Years
- -10%
- 3 Years
- -14%
- 1 Year
- -33%
- 10 Years
- 1%
- 5 Years
- -1%
- 3 Years
- -4%
- Last Year
- -9%
Medi Caps Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹2.79 cr, up 3.7% from ₹2.69 cr a year earlier. Net profit was ₹-2.23 cr, up 36.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 8.29 | 4.02 | 6.97 | 2.69 | 2.02 | 4.3 | 3.45 | 2.79 |
| Expenses | 7.84 | 5.8 | 7.2 | 6.07 | 4.93 | 5.36 | 5.51 | 4.62 |
| Operating profit | 0.45 | -1.78 | -0.23 | -3.38 | -2.91 | -1.06 | -2.06 | -1.83 |
| OPM % | 5.43% | -44.28% | -3.30% | -125.65% | -144.06% | -24.65% | -59.71% | -65.59% |
| Other income | 0.29 | 0.16 | 2.14 | 0.33 | 1.53 | 0.76 | 5.59 | 0.05 |
| Interest | 0 | 0 | 0.02 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0.43 | 0.43 | 0.44 | 0.44 | 0.44 | 0.44 | 0.5 | 0.45 |
| Profit before tax | 0.31 | -2.05 | 1.45 | -3.5 | -1.82 | -0.74 | 3.03 | -2.23 |
| Tax % | 0.00% | 0.00% | -18.62% | 0.00% | 0.00% | 4.05% | -0.33% | 0.00% |
| Net profit | 0.31 | -2.05 | 1.72 | -3.49 | -1.82 | -0.77 | 3.04 | -2.23 |
| EPS (₹) | 0.25 | -1.64 | 1.38 | -2.80 | -1.46 | -0.62 | 2.44 | -1.79 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Medi Caps Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.04 | 53.7 | 51.79 | 43.05 | 57.42 | 69.87 | 49.37 | 27.35 | 25.48 | 12.45 | 12.56 |
| Operating profit | 1.61 | 2.17 | 4.72 | -6.75 | 10.97 | 10.07 | 5.19 | 0 | -1.8 | -9.41 | -7.86 |
| OPM % | 3.66% | 4.04% | 9.11% | -15.68% | 19.10% | 14.41% | 10.51% | 0.00% | -7.06% | -75.58% | -62.58% |
| Net profit | 1.37 | 1.15 | 5.39 | -5.85 | 11.13 | 10.08 | 1.76 | -2.24 | -0.57 | -3.04 | -1.78 |
| EPS (₹) | 1.10 | 0.92 | 4.32 | -4.69 | 8.93 | 8.08 | 1.41 | -1.80 | -0.46 | -2.44 | -1.43 |
TTM is the trailing twelve months to the most recent quarter.
Medi Caps Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves | 76.62 | 77.75 | 83.13 | 78.48 | 92.24 | 103.79 | 106.10 | 108.51 | 108.81 | 99.14 |
| Borrowings | 0.09 | 0.17 | 0.12 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other liabilities | 8.19 | 10.52 | 10.89 | 4.20 | 10.11 | 14.09 | 7.42 | 6.31 | 4.14 | 3.85 |
| Total liabilities | 97.37 | 100.91 | 106.61 | 95.21 | 114.82 | 130.35 | 125.99 | 127.29 | 125.42 | 115.46 |
| Fixed assets | 62.14 | 61.03 | 59.80 | 57.30 | 58.12 | 59.31 | 58.91 | 58.65 | 57.18 | 56.29 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.97 | 0.54 | 0.24 | 0.00 | 0.00 | 0.08 | 0.00 |
| Investments | 7.83 | 11.18 | 16.35 | 21.97 | 29.41 | 30.67 | 32.07 | 38.38 | 43.04 | 34.82 |
| Other assets | 27.40 | 28.70 | 30.46 | 14.97 | 26.75 | 40.13 | 35.01 | 30.26 | 25.12 | 24.35 |
| Total assets | 97.37 | 100.91 | 106.61 | 95.21 | 114.82 | 130.35 | 125.99 | 127.29 | 125.42 | 115.46 |
As reported by the company. Total assets equal total liabilities by construction.
Medi Caps Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4.02 | 4.20 | 5.96 | 4.63 | 15.32 | 7.02 | -6.08 | 6.94 | 5.07 | -7.02 |
| Cash from investing | 2.57 | -4.09 | -5.75 | -5.80 | -9.70 | -4.08 | -2.56 | -7.73 | -4.98 | 7.11 |
| Cash from financing | -5.76 | 0.08 | -0.05 | -0.06 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash flow | 0.83 | 0.20 | 0.16 | -1.23 | 5.56 | 2.95 | -8.64 | -0.79 | 0.09 | 0.09 |
| Free cash flow | 9.11 | 3.51 | 5.37 | 3.38 | 13.06 | 4.23 | -7.24 | 6.59 | 4.74 | -7.87 |
| CFO / operating profit | 270% | 202% | 128% | -69% | 140% | 70% | -58% | — | -267% | 74% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Medi Caps Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 1.48% | 1.56% | 5.77% | -6.58% | 11.59% | 8.78% | 3.70% | -1.17% | -2.12% | -9.19% |
| Debtor days | 74.09 | 88.57 | 90.56 | 37.39 | 40.62 | 52.61 | 62.55 | 144.40 | 125.92 | 202.88 |
| Inventory days | 230.21 | 148.16 | 163.52 | 75.29 | 83.45 | 156.60 | 121.72 | 243.05 | 120.79 | 209.59 |
| Days payable | 75.75 | 90.99 | 96.26 | 26.94 | 76.61 | 154.35 | 48.72 | 77.49 | 59.64 | 34.22 |
| Cash conversion cycle | 228.56 | 145.73 | 157.82 | 85.74 | 47.46 | 54.85 | 135.55 | 309.96 | 187.06 | 378.25 |
| Working capital days | 147.11 | 113.17 | 127.42 | 84.70 | 65.41 | 87.66 | 200.50 | 324.16 | 304.12 | 598.07 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Medi Caps Ltd-$ shareholding pattern
Promoters held 51.44% at Jun 2026, up from 50.76% at Jun 2025. DIIs 0.02%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.42% | 50.61% | 50.76% | 50.76% | 50.76% | 50.76% | 51.36% | 51.44% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.02% | 0.02% | 0.02% |
| Public | 49.54% | 49.35% | 49.21% | 49.21% | 49.19% | 49.21% | 48.61% | 48.54% |
| No. of shareholders | 11,255 | 11,176 | 11,033 | 10,851 | 10,692 | 10,493 | 10,349 | 10,209 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Medi Caps Ltd-$ corporate filings
- Certificate for Compliance under Reg. 74(5) of SEBI (D.P.) Regulation 2018 for the quarter ended 30.09.2026Company Updatelow impact
- The trading window shall remain closed for trading in share of the company from 1st October 2026 till completion of the 48 hours of declaration of unaudited standalone and consolidated ....Insider Trading / SASTlow impact
- Medi-Caps Limited confirms board appointments and re-appointment of CMD following 43rd AGMCompany Updatelow impact
Cruxal's analysis: Medi-Caps Limited has formally disclosed the outcomes of its 43rd Annual General Meeting…
Read the full analysis - Medi-Caps Limited announces successful conclusion of 43rd AGM with shareholder approval for all resolutionsAGM/EGMlow impact
Cruxal's analysis: Medi-Caps Limited has successfully concluded its 43rd Annual General Meeting held on 22nd…
Read the full analysis - Medi-Caps Limited Concludes 43rd Annual General Meeting; Re-appoints Managing DirectorAGM/EGMlow impact
Cruxal's analysis: Medi-Caps Limited has successfully concluded its 43rd Annual General Meeting held on 22nd…
Read the full analysis - Medi-Caps Limited Announces 43rd Annual General Meeting (AGM) for September 22, 2026Company Updatelow impact
Cruxal's analysis: Medi-Caps Limited has issued a formal notice for its 43rd Annual General Meeting…
Read the full analysis - Medi-Caps Limited Announces 43rd Annual General Meeting Details for September 2026AGM/EGMlow impact
Cruxal's analysis: Medi-Caps Limited has issued a formal notification regarding its 43rd Annual General…
Read the full analysis - Medi Caps Ltd issues notice for physical dispatch of documents to shareholders with unregistered email addressesCompany Updatelow impact
Cruxal's analysis: Medi Caps Ltd has initiated the process of dispatching physical letters to shareholders…
Read the full analysis - Medi Caps Ltd submits 43rd Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Medi Caps Ltd has filed its 43rd Annual Report for the financial year 2025-26 in…
Read the full analysis - Medi-Caps Limited Announces 43rd AGM and Key Management ReappointmentsAGM/EGMlow impact
Cruxal's analysis: Medi-Caps Limited has scheduled its 43rd Annual General Meeting for September 22, 2026…
Read the full analysis - Medi Caps Ltd announces newspaper publication for 43rd Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Medi Caps Ltd has submitted a newspaper publication regarding the information of its 43rd…
Read the full analysis - Medi Caps Ltd updates authorized personnel for materiality disclosures under SEBI LODR Regulation 30(5)Company Updatelow impact
Cruxal's analysis: Medi Caps Ltd has filed a disclosure regarding the authorization of specific personnel…
Read the full analysis - Medi-Caps Limited Reports Continued Financial Weakness with Net Loss of 2.23 Crore for Q1 FY2027Company Updatehigh impact
Cruxal's analysis: Medi-Caps Limited has reported a standalone net loss of 2.23 crore for the quarter ended…
Read the full analysis - Medi-Caps Limited Announces Internal Leadership Restructuring with Key Management AppointmentsCompany Updatelow impact
Cruxal's analysis: Medi-Caps Limited has disclosed an internal leadership transition where Mrs. Saloni Garg…
Read the full analysis - Medi-Caps Limited announces leadership restructuring with re-appointment of CMD and appointment of new CFO and Whole-Time DirectorCompany Updatelow impact
Cruxal's analysis: Medi-Caps Limited has announced the re-appointment of Mr. Alok K. Garg as Chairman cum…
Read the full analysis - Medi-Caps Limited Reports Q1 FY2027 Financial Results and Announces Key Management ChangesBoard Meetingmedium impact
Cruxal's analysis: Medi-Caps Limited reported a consolidated net loss of 2.23 crore for the quarter ended 30…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.